D.E. Shaw & Co’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

D.E. Shaw & Co’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.17M	Buy	+5,811	New	+$1.2M	﹤0.01%	3336

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

D.E. Shaw & Co's FBT Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 5,811 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #3336 among its holdings.

307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

D.E. Shaw & Co held 5,811 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.17M as of Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new D.E. Shaw & Co position in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3336 holding.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.